Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.
about
Update in Cystic Fibrosis 2014A genome-wide screen identifies a single beta-defensin gene cluster in the chicken: implications for the origin and evolution of mammalian defensinsBeta-defensin genomic copy number is not a modifier locus for cystic fibrosis.Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptidesEnterohemorrhagic and enteropathogenic Escherichia coli evolved different strategies to resist antimicrobial peptidesThe Unusual Resistance of Avian Defensin AvBD7 to Proteolytic Enzymes Preserves Its Antibacterial ActivityNew approaches to making the microenvironment of the female reproductive tract hostile to HIV.Alpha-defensins in enteric innate immunity: functional Paneth cell alpha-defensins in mouse colonic lumen.Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodiesProteases Revisited: Roles and Therapeutic Implications in Fibrosis.Alveolar inflammation in cystic fibrosis.Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis.Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract.miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production.Clinical significance of microbial infection and adaptation in cystic fibrosis.Corruption of innate immunity by bacterial proteases.Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatmentEffects of airway surface liquid pH on host defense in cystic fibrosisMechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria.Pro-moieties of antimicrobial peptide prodrugs.Cholesteryl esters are elevated in the lipid fraction of bronchoalveolar lavage fluid collected from pediatric cystic fibrosis patients.Cationic antimicrobial peptides - an update.Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic TherapyPathogen-host interactions in Pseudomonas aeruginosa pneumoniaElastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease.Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.Bacterial Evasion of Host Antimicrobial Peptide DefensesOcular surface expression and in vitro activity of antimicrobial peptides.The role of cathelicidin and defensins in pulmonary inflammatory diseases.Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosisThe role of epithelial beta-defensins and cathelicidins in host defense of the lung.Human antimicrobial proteins effectors of innate immunity.Proteases and cystic fibrosis.Differential Processing of {alpha}- and {beta}-Defensin Precursors by Matrix Metalloproteinase-7 (MMP-7).Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.Vitamin D, innate immunity and upper respiratory tract infection.New antimicrobial strategies in cystic fibrosis.Understanding the roles of gingival beta-defensins.Failure of respiratory defenses in the pathogenesis of bacterial pneumonia of cattle.Secreted mucosal antimicrobials in the female reproductive tract that are important to consider for HIV prevention.
P2860
Q22306307-C8BCD1F8-7292-41F9-9878-E69213C6DC9DQ24804242-2C76E2AA-4A6D-4E1C-9120-88BDF6739046Q24813881-BA3BF2F4-D50B-4942-B460-8409277E6863Q26861137-ACB2DAFD-56C7-4C70-A83D-7BCB042C0D85Q26865058-8CD972B4-57F9-439B-9DEF-FE8FE46E213FQ28553719-24EDFD36-96B2-4FE1-9AFF-F395B5CDAD30Q30398454-6DF329FF-035A-4545-ADD5-FB29F7B255ECQ31083153-ECB56819-6F47-4651-AF69-163A0B5B90A0Q33627673-7A622031-4523-422C-AAC7-0DFC061FE333Q33795055-D9CF364E-1860-4DDA-BF49-7A0280AB2EFCQ33905883-5B429B7F-EBB8-42C0-B56C-DD3A90BC47EAQ34043367-1826B976-7F01-4BED-9D84-B7956E9CC046Q34295695-C3F031A8-19F4-40F0-9198-993A6F2C8F44Q34480433-C8729C50-787A-404A-8400-113976BC8CB4Q34491552-4B9470AA-C086-47CF-BF90-3ECFD6ACB890Q35003110-F5E71106-D745-411E-A00D-4D5200A8F7BEQ35179153-0D71B6CC-A550-41D9-9CC2-40182A2ABB81Q35498296-F88FC210-4A1A-41D9-B389-B9AA80D789E8Q35541353-2ED124A1-27C0-4979-8F51-7DE47C65DA72Q35543287-2DA65523-087B-4319-8D6F-E4068B632D47Q35546970-4CB0973C-B3BD-499D-8B78-FBB2E9686FF1Q35680641-B7CE6798-4281-4419-9CA5-4F42592D306BQ35817400-E628C9EA-429D-49B7-BB36-B21C82BF48A5Q36032639-E51C8250-3F7C-4B3F-93AF-03A1242024DFQ36032652-184851FA-8CD2-4FD3-9E6C-EDE6B65BE98CQ36114167-3F4A9C11-8B5C-4071-A043-BE289A11C4E0Q36720179-3973B9B2-5FB0-4BDE-9BA7-1393B0AB7E49Q36726165-EE3C2442-EC11-4DCE-B588-218893CF9CFBQ36922272-D13960CC-C581-408E-9745-C06CB4F61561Q36973716-0D741F9E-AC14-4930-9EE5-7EB58F6A42B5Q37030668-B4111210-D518-4298-9D68-8163F1AAA157Q37053332-DEC1BC52-468D-4645-9718-B0F72F3E8BEFQ37131650-E9778CE6-DF03-46BD-A76E-81D8C299CC1FQ37136740-96D358B2-A3A5-4B7A-BA40-B219E950ACFAQ37447482-1250E7FA-EAB5-496F-8622-85C39C237C92Q37672676-AFCBCD7D-E0C4-45EB-994E-7E02D2DECF49Q37804379-A2F040D6-450A-4C78-9616-8FD03214E700Q37990507-D2097CC3-43C4-4B92-9E08-9D915E466642Q38136000-92F2B22E-ED51-47F4-B986-FBE491C06481Q38206217-8E8F7DD5-3DB1-46FD-A049-F8A3965BF0A4
P2860
Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.
@ast
Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.
@en
type
label
Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.
@ast
Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.
@en
prefLabel
Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.
@ast
Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.
@en
P2093
P1476
Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.
@en
P2093
Catherine M Greene
Noel G McElvaney
Rodney L Levine
Shane O'Neill
Stephen G Smith
P304
P356
10.4049/JIMMUNOL.171.2.931
P407
P577
2003-07-01T00:00:00Z